We’re getting ready to head over to PATH later today for our big event, “Reinventing Biotech’s Business Model.” More than 245 people have registered, so this is shaping up to be the biggest conference we’ve done so far at Xconomy Seattle.
For those of you want to follow some of the highlights in real-time, the searchable hash tag on Twitter is #xcbiobiz. Given the lineup of great speakers we have coming from around the country, you can bet there will be some great insights that will be discussed inside and outside the room.
Registration and networking starts at 1 pm, and the program will run from 2 pm to 6 pm, with a half-hour networking break in the middle. We’ve got a terrific group of people experimenting with new models, so I have no doubt that a lot of creative sparks will fly. Here’s one last glimpse at the program. See you there this afternoon.
1 pm Registration and networking
2 pm Welcoming remarks, PATH & Xconomy.
2:10 pm Opening keynote chat.
Corey Goodman, venBio.
John Mendlein, aTyr Pharma, Fate Therapeutics
Luke Timmerman, Xconomy (moderator)
2:40 pm Experiments with new business models. 20 minutes each.
Ed Saltzman, president, Defined Health (moderator)
Brian Atwood and Peppi Prasit, Versant Ventures/Inception Sciences
Kathy Glaub, Plexxikon
Steve Tregay, Forma Therapeutics
Thong Le & Bruce Montgomery, Cardeas Pharma
4 pm Networking Break
4:30 pm Experiments with new models
Alex Lash, reporter/editor, Startup/In Vivo (moderator)
Carl Weissman & David McElligott, Groove Biopharma
Heather Franklin, Blaze Bioscience
Cliff Stocks, Theraclone Sciences
5:30 pm Closing Keynote Chat
Kevin Starr, Third Rock Ventures
John Maraganore, Alnylam Pharmaceuticals
Luke Timmerman, Xconomy (moderator)
6 pm Networking reception
7 pm End
